Crowdonomics
Health Journal

Reg CF · Class B Shares · Sep 2019

ClosedReg CFCommon Equity
via StartEngine · last checked Sep 28, 2026
Raised
$1.4K / $1.1M max
0% of ceiling · target hit day 23
Investors
3
$466.7 avg
Post-money valuation
$20M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$19K$9K$0
47240
Sep 23, 2019 · openedDec 25, 2019 · last reading
Target ($10K) hit — Oct 16, 2019, day 23Deadline Dec 24, 2019

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Sep 28, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2017–FY2018 · hover for source
$733K
−$100K
FY2017
$619K
$3K
FY2018
RevenueNet income
Metric
FY2017 reviewed
FY2018 reviewed
Income statement
Revenue
$733,014
$618,778
Cost of goods sold
$808,962
$594,555
Gross margin
-10%
4%
Net income
-$99,667
$2,773
Taxes paid
$0
$0
Balance sheet
Cash
$6,103
$13,210
Accounts receivable
$57,712
$14,033
Total assets
$63,815
$27,243
Short-term debt
$30,650
$28,011
Long-term debt
$82,347
$54,336
Total liabilities
$112,997
$82,347
Other
Headcount
—
10

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$20M
Post-money$20M
Price / share$5.00
Shares offered2,000

Offering details

Target$10,000
Max$1,070,000
Min investment$400
OpenedSep 23, 2019
DeadlineDec 24, 2019
ClosedDec 24, 2019
Days active92

Links & provenance

Source: SEC EDGAR
0001665160-19-000954
Last synced Sep 28, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.